The wait is finally over. On April 14, 2022, the Food and Drug Administration (FDA) published its guidance for industry #256 (GFI 256), describing FDA’s position on the legality of...
Source: jdsupra.com
Stay updated with breaking news from Between Compounding Drugs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The wait is finally over. On April 14, 2022, the Food and Drug Administration (FDA) published its guidance for industry #256 (GFI 256), describing FDA’s position on the legality of...